QurAlis presents! Excited to have our CSO Dan Elbaum as a featured speaker at the 2nd Annual Neurodegeneration Targets conference taking place next week. Dan's talk is entitled, "Recent Advances in the Development of Splice-Switching #Oligonucleotides for #CNS Diseases." #precisionmedicine #neurodegenerativediseases
QurAlis’ Post
More Relevant Posts
-
Researchers are abuzz about the potential applications of Methylene Blue in combatting neurodegenerative diseases. Our latest blog post explores the science behind its activity and what this means for the future of treatment. 👉 Read now https://bit.ly/4eV2HgP #MethyleneBlue #AntiAging #MitochondrialHealth #Longevity #Sanux
To view or add a comment, sign in
-
New research from the Inherited #Neuropathy Consortium (INC): ✅ Reporting Cases of Intermediate Nerve Conduction Velocity in Patients with #CharcotMarieTooth Disease Type 1A Listen and read more: https://lnkd.in/dxjMzMDs
To view or add a comment, sign in
-
Researchers are abuzz about the potential applications of Methylene Blue in combatting neurodegenerative diseases. Our latest blog post explores the science behind its activity and what this means for the future of treatment. 👉 Read now https://bit.ly/4eV2HgP #MethyleneBlue #AntiAging #MitochondrialHealth #Longevity #Sanux
To view or add a comment, sign in
-
Researchers are abuzz about the potential applications of Methylene Blue in combatting neurodegenerative diseases. Our latest blog post explores the science behind its activity and what this means for the future of treatment. 👉 Read now https://bit.ly/4eV2HgP #MethyleneBlue #AntiAging #MitochondrialHealth #Longevity #Sanux
To view or add a comment, sign in
-
Rare Disease Day is tomorrow, Thursday, February 29. Its purpose is to raise awareness for rare diseases, and improve access to treatment and medical representation for individuals with rare diseases and their families. At SequenceMD, our primary focus is on the testing, diagnosis and management of unresolved symptoms, undiagnosed conditions and rare diseases for patients of all ages. If you, a family member or friend have had health issues that continue without answers — or have been diagnosed with a rare disease — now’s the time to get to the root of what’s going on with your health. A genetic diagnosis can reveal insights into your medical history, prepare you for what’s ahead, and inform a customized, precision care plan to maintain or improve your health. LEARN MORE HERE: https://lnkd.in/ePGHRdnd #rarediseaseday #genetictesting #genetics #sequencemd #caremanagement #diagnosis #raredisorders #neurogenetic #raregeneticdisorders #metabolicconditions #geneticdisorders
To view or add a comment, sign in
-
Did you know?💡Millions of people worldwide lack information about their rare disease. Improving access to information is crucial for diagnosis and treatment, research, patient empowerment, and support networks for people with rare diseases and their family's. It is a problem that Geneyx Genomex Ltd. and other companies are working to resolve. 🌍🌎🌏Join us to raise awareness about rare diseases. #PersonalizedMedicine #rarediseaseawareness #GeneticResearch #HumanGenetics #MolecularBiology
To view or add a comment, sign in
-
More than 700,000 people worldwide live with myasthenia gravis (MG), a rare, autoantibody-driven disease for which there is no cure. Autoantibody diseases are caused by pathogenic antibodies, made by one’s own body, that attack critical organs and tissues. For patients with MG, this means fluctuating weakness of the skeletal muscles, which can lead to symptoms like difficulty speaking and swallowing. Since symptoms can be invisible at times, it can sometimes be difficult to diagnose. This #MGAwarenessMonth, we’re committed to developing treatment options for MG patients worldwide by advancing autoantibody research. Learn more about MG: https://lnkd.in/eGZYiJjH #JNJNeuroscience #JNJImmunology
To view or add a comment, sign in
-
#Glut1Deficiency Syndrome is a #raredisease. It is thought that there are around 100 diagnosed cases in the UK and Ireland. Recent studies have estimated true prevalence to be at least 1:21,000, so the vast majority of individuals remain undiagnosed. Bringing awareness to rare diseases is critical it helps to focus attention on the specific challenges faced by those affected and their families, from struggling to receive the correct diagnosis to limited knowledge among healthcare professionals, people often struggle for support. Help us by sharing our message of support on Rare Disease Day. #TogetherForGlut1 #rarediseaseday2024 Genetic Alliance UK
To view or add a comment, sign in
-
Sometimes I have the privilege to work in disease areas people have rarely heard of, for conditions I hope no one ever has to have. Progressive Familial Intrahepatic Cholestasis (PFIC) is an umbrella term that represents a group of rare genetic liver disorders. The hallmark symptom of PFIC is a severe and debilitating itch. The disease typically presents in infancy or early childhood. The exact prevalence is unknown, but PFIC is estimated to affect 1 in 50,000-100,000 people worldwide. There is currently no cure for PFIC and related diseases. Learn more by visiting www.pfic.org. Together, we can make a difference. #StrongerTogether #ItchingForACure
To view or add a comment, sign in
-
Dr Shlomi Haar (UK DRI Care Research & Technology) is developing #DigitalBiomarkers that can provide cost-effective, objective, and robust measures to track progression of neurodegenerative disease. Hear more about his work⬇️📽️
To view or add a comment, sign in
8,654 followers